- Home
- CMP vs CSTL Comparison
CMP vs CSTL Comparison
Compare CMP & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMP
- CSTL
- Stock Information
- Founded
- CMP 1993
- CSTL 2007
- Country
- CMP United States
- CSTL United States
- Employees
- CMP N/A
- CSTL N/A
- Industry
- CMP Other Metals and Minerals
- CSTL Medical Specialities
- Sector
- CMP Basic Materials
- CSTL Health Care
- Exchange
- CMP Nasdaq
- CSTL Nasdaq
- Market Cap
- CMP 781.2M
- CSTL 661.7M
- IPO Year
- CMP 2003
- CSTL 2019
- Fundamental
- Price
- CMP $17.22
- CSTL $23.74
- Analyst Decision
- CMP Hold
- CSTL Strong Buy
- Analyst Count
- CMP 3
- CSTL 6
- Target Price
- CMP $20.00
- CSTL $37.67
- AVG Volume (30 Days)
- CMP 355.2K
- CSTL 256.3K
- Earning Date
- CMP 12-15-2025
- CSTL 11-03-2025
- Dividend Yield
- CMP N/A
- CSTL N/A
- EPS Growth
- CMP N/A
- CSTL N/A
- EPS
- CMP N/A
- CSTL N/A
- Revenue
- CMP $1,225,200,000.00
- CSTL $346,269,000.00
- Revenue This Year
- CMP $12.05
- CSTL N/A
- Revenue Next Year
- CMP $4.15
- CSTL N/A
- P/E Ratio
- CMP N/A
- CSTL N/A
- Revenue Growth
- CMP 7.27
- CSTL 20.40
- 52 Week Low
- CMP $8.60
- CSTL $14.59
- 52 Week High
- CMP $22.69
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- CMP 39.68
- CSTL 54.78
- Support Level
- CMP $17.54
- CSTL $23.31
- Resistance Level
- CMP $18.91
- CSTL $24.86
- Average True Range (ATR)
- CMP 0.93
- CSTL 0.86
- MACD
- CMP -0.15
- CSTL 0.08
- Stochastic Oscillator
- CMP 9.28
- CSTL 59.42
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.